265 related articles for article (PubMed ID: 27108664)
1. Effects of intraplantar botulinum toxin-B on carrageenan-induced changes in nociception and spinal phosphorylation of GluA1 and Akt.
Sikandar S; Gustavsson Y; Marino MJ; Dickenson AH; Yaksh TL; Sorkin LS; Ramachandran R
Eur J Neurosci; 2016 Jul; 44(1):1714-22. PubMed ID: 27108664
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior.
Marino MJ; Terashima T; Steinauer JJ; Eddinger KA; Yaksh TL; Xu Q
Pain; 2014 Apr; 155(4):674-684. PubMed ID: 24333775
[TBL] [Abstract][Full Text] [Related]
3. Inflammation-induced GluA1 trafficking and membrane insertion of Ca
Wigerblad G; Huie JR; Yin HZ; Leinders M; Pritchard RA; Koehrn FJ; Xiao WH; Bennett GJ; Huganir RL; Ferguson AR; Weiss JH; Svensson CI; Sorkin LS
Exp Neurol; 2017 Jul; 293():144-158. PubMed ID: 28412220
[TBL] [Abstract][Full Text] [Related]
4. The effects of intraplantar and intrathecal botulinum toxin type B on tactile allodynia in mono and polyneuropathy in the mouse.
Park HJ; Marino MJ; Rondon ES; Xu Q; Yaksh TL
Anesth Analg; 2015 Jul; 121(1):229-238. PubMed ID: 26039418
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Makriyannis A; Hohmann AG
Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
[TBL] [Abstract][Full Text] [Related]
6. Carrageenan induced phosphorylation of Akt is dependent on neurokinin-1 expressing neurons in the superficial dorsal horn.
Choi JI; Koehrn FJ; Sorkin LS
Mol Pain; 2012 Jan; 8():4. PubMed ID: 22243518
[TBL] [Abstract][Full Text] [Related]
7. Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice.
Matak I; Tékus V; Bölcskei K; Lacković Z; Helyes Z
Neuroscience; 2017 Sep; 358():137-145. PubMed ID: 28673722
[TBL] [Abstract][Full Text] [Related]
8. Spinal botulinum neurotoxin B: effects on afferent transmitter release and nociceptive processing.
Huang PP; Khan I; Suhail MS; Malkmus S; Yaksh TL
PLoS One; 2011 Apr; 6(4):e19126. PubMed ID: 21559464
[TBL] [Abstract][Full Text] [Related]
9. Peripheral and/or central effects of racemic-, S(+)- and R(-)-flurbiprofen on inflammatory nociceptive processes: a c-Fos protein study in the rat spinal cord.
Buritova J; Besson JM
Br J Pharmacol; 1998 Sep; 125(1):87-101. PubMed ID: 9776348
[TBL] [Abstract][Full Text] [Related]
10. The contribution of GABAB receptor-mediated events to inflammatory pain processing: carrageenan oedema and associated spinal c-Fos expression in the rat.
Buritova J; Chapman V; Honoré P; Besson JM
Neuroscience; 1996 Jul; 73(2):487-96. PubMed ID: 8783264
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
Buritova J; Le Guen S; Fournié-Zaluski MC; Roques BP; Besson JM
Eur J Pain; 2003; 7(3):241-9. PubMed ID: 12725847
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effects of A1 and A2 type botulinum toxins on carrageenan-induced hyperalgesia in rat.
Shin MC; Yukihira T; Ito Y; Akaike N
Toxicon; 2013 Mar; 64():12-9. PubMed ID: 23270755
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal P/Q- and R-type calcium channel blockade of spinal substance P release and c-Fos expression.
Terashima T; Xu Q; Yamaguchi S; Yaksh TL
Neuropharmacology; 2013 Dec; 75():1-8. PubMed ID: 23810829
[TBL] [Abstract][Full Text] [Related]
14. A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Suplita RL; Hohmann AG
Neuroscience; 2003; 117(3):659-70. PubMed ID: 12617970
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A and gabapentin attenuate postoperative pain and NK1 receptor internalization in rats.
Li X; Guo R; Sun Y; Li H; Ma D; Zhang C; Guan Y; Li J; Wang Y
Neurochem Int; 2018 Jun; 116():52-62. PubMed ID: 29572051
[TBL] [Abstract][Full Text] [Related]
16. Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain.
Zychowska M; Rojewska E; Makuch W; Luvisetto S; Pavone F; Marinelli S; Przewlocka B; Mika J
Eur J Pharmacol; 2016 Nov; 791():377-388. PubMed ID: 27619001
[TBL] [Abstract][Full Text] [Related]
17. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
Chapman V; Buritova J; Honoré P; Besson JM
J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive action of botulinum toxin type A in carrageenan-induced mirror pain.
Drinovac Vlah V; Bach-Rojecky L; Lacković Z
J Neural Transm (Vienna); 2016 Dec; 123(12):1403-1413. PubMed ID: 27506955
[TBL] [Abstract][Full Text] [Related]
19. Peripheral inflammation induces tumor necrosis factor dependent AMPA receptor trafficking and Akt phosphorylation in spinal cord in addition to pain behavior.
Choi JI; Svensson CI; Koehrn FJ; Bhuskute A; Sorkin LS
Pain; 2010 May; 149(2):243-253. PubMed ID: 20202754
[TBL] [Abstract][Full Text] [Related]
20. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.
Quintão NL; da Silva GF; Antonialli CS; de Campos-Buzzi F; Corrêa R; Filho VC
Anesth Analg; 2010 Mar; 110(3):942-50. PubMed ID: 20185671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
